Methadone maintenance treatment: A Canadian perspective

Brands, Bruna; Marsh, David C.
August 1997
CMAJ: Canadian Medical Association Journal;08/15/97, Vol. 157 Issue 4, p399
Academic Journal
Editorial. Discusses the study by Latowsky and Kallen in the August 15, 1997 edition of the Canadian Medical Association Journal which addressed issues surrounding methadone maintenance treatment. The social tragedy of heroin; The growing problem of opioid use in Canada; Work of the Addiction Research Foundation, Toronto, Ontario; Evaluation of Latowsky and Kallen study; Value in providing methadone maintenance as part of primary medical care; Solutions already applied in Canada.


Related Articles

  • Optimal Daily Methadone Dosage to Treat Opioid Dependence. Huffman, Grace Brooke // American Family Physician;9/1/1999, Vol. 60 Issue 3, p989 

    Presents an abstract of the study `Moderate- vs. High-Dose Methadone in the Treatment of Opioid Dependence: A Randomized Trial,' by E.C. Strain et al., published on the March 17, 1999 issue of the `Journal of American Medical Association.'

  • Methadone Maintenance. Stancliff, Sharon // American Family Physician;6/15/2001, Vol. 63 Issue 12, p2335 

    Editorial. Comments on methadone maintenance as an effective treatment for opioid addiction. Dosage requirements; Side effects; Role of primary care physicians in methadone therapy.

  • Methadone Therapy for Opioid Dependence. Krambeer, Laurie Limpitlaw // American Family Physician;6/15/2001, Vol. 63 Issue 12, p2404 

    The 1999 Federal regulations extend the treatment options of methadone-maintained opioid-dependent patients from specialized clinics to office-based opioid therapy (OBOT). OBOT allows primary care physicians to coordinate methadone therapy in this group with ongoing medical care. This patient...

  • High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Donny, Eric C.; Walsh, Sharon L.; Bigelow, George E.; Eissenberg, Thomas; Stitzer, Maxine L. // Psychopharmacology;2002, Vol. 161 Issue 2, p202 

    Rationale: The efficacy of methadone for treating heroin dependence derives, in part, from suppression of opiate withdrawal and attenuation of the effects of heroin. Objectives: The purpose of this double-blind, within-subject, inpatient study was to determine whether larger doses of methadone,...

  • Mainstreaming methadone maintenance treatment: The role of the family physician. Latowsky, Mark; Kallen, Evelyn // CMAJ: Canadian Medical Association Journal;08/15/97, Vol. 157 Issue 4, p395 

    Editorial. Remarks that although methadone maintenance achieves good outcomes for opioid addiction, its effectiveness is limited by the stigmatization and social disengagement of patients. Misperceptions about methadone maintenance and their implications; Experience of stigmatization;...

  • Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey. CURCIO, F.; FRANCO, T.; TOPA, M.; BALDASSARRE, C. // European Review for Medical & Pharmacological Sciences;2011, Vol. 15 Issue 8, p871 

    Background and Objectives: Buprenorphine and methadone are widely used for the treatment of opioid dependence, but their diversion and/or misuse are frequent. In principle, buprenorphine/naloxone combination therapy should be associated with a lower frequency of drug abuse/misuse than methadone....

  • Study examines public health implications of lack of methadone treatment in prisons.  // Rhode Island Medical Journal;May2013, Vol. 96 Issue 5, p66 

    The article focuses on the study conducted by researchers from the Center for Prisoner Health and Human Rights which examines the public health implications of the mandatory discontinuation of methadone treatment for opioid-dependent prisoners in the U.S.

  • Variability of QT Interval Measurements in Opioid- Dependent Patients on Methadone. Worster, Andrew; Varenbut, Michael; Daiter, Jeff; Nair, Girish M.; Plater-Zyberk, Carolyn; Griffith, Lauren; Jihui Ma; Zachos, Constantine; Sivilotti, Marco L. A. // Canadian Journal of Addiction;Jun2014, Vol. 5 Issue 2, p10 

    Background: Methadone can prolong the QT interval, a precursor to ventricular dysrhythmias. Measurement of the QT interval can vary with intrinsic and extrinsic factors. Our objective was to assess the agreement and repeatability between different QT interval measurements. Methods: We recorded...

  • Methadone and QTc screening: Weighing the risks and benefits. Nolan, Seonaid; Wood, Evan // Canadian Journal of Addiction;Jun2014, Vol. 5 Issue 2, p17 

    The article discusses the role of methadone therapy in prolonging of the corrected QT (QTc) interval on the electrocardiogram (ECG), and increasing the risk of life threatening cardiac arrhythmia. It is stated that a QTc of 500 milliseconds or more can lead to sudden cardiac death (SCD); and 2...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics